Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience.

MLA

Zelefsky, Michael J., et al. “Predicting Biochemical Tumor Control after Brachytherapy for Clinically Localized Prostate Cancer: The Memorial Sloan-Kettering Cancer Center Experience.” Brachytherapy, vol. 11, no. 4, July 2012, pp. 245–49. EBSCOhost, https://doi.org/10.1016/j.brachy.2011.08.003.

APA

Zelefsky, M. J., Chou, J. F., Pei, X., Yamada, Y., Kollmeier, M., Cox, B., Zhang, Z., Schechter, M., Cohen, G. N., & Zaider, M. (2012). Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience. Brachytherapy, 11(4), 245–249. https://doi.org/10.1016/j.brachy.2011.08.003

Chicago

Zelefsky, Michael J, Joanne F Chou, Xin Pei, Yoshiya Yamada, Marisa Kollmeier, Brett Cox, Zhigang Zhang, Michael Schechter, Gil’ad N Cohen, and Marco Zaider. 2012. “Predicting Biochemical Tumor Control after Brachytherapy for Clinically Localized Prostate Cancer: The Memorial Sloan-Kettering Cancer Center Experience.” Brachytherapy 11 (4): 245–49. doi:10.1016/j.brachy.2011.08.003.